Literature DB >> 20981677

ENERCA clinical recommendations for disease management and prevention of complications of sickle cell disease in children.

Mariane de Montalembert1, Alina Ferster, Raffaella Colombatti, David C Rees, Beatrice Gulbis.   

Abstract

Universal neonatal screening is performed in the United States, England, the Netherlands, and several cities in Belgium, with selective screening targeted on "high-risk" population in France (globally, one quarter of all the babies born in France are screened). Newborns diagnosed with a major sickle cell syndrome (SCD) should be referred to a designated pediatric sickle cell centre, and the parents are informed that their child has SCD; this may be in the sickle cell centre by an expert physician or in the community by an experienced nurse counsellor. The pediatric sickle cell centre should organize the care of the baby.

Entities:  

Mesh:

Year:  2011        PMID: 20981677     DOI: 10.1002/ajh.21865

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  7 in total

Review 1.  Management of sickle cell disease in the community.

Authors:  Valentine Brousse; Julie Makani; David C Rees
Journal:  BMJ       Date:  2014-03-10

2.  Sickle cell disease: a comprehensive program of care from birth.

Authors:  Mariane de Montalembert; Léon Tshilolo; Slimane Allali
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

Review 3.  How we manage iron overload in sickle cell patients.

Authors:  Thomas D Coates; John C Wood
Journal:  Br J Haematol       Date:  2017-03-14       Impact factor: 6.998

4.  An Educational Study Promoting the Delivery of Transcranial Doppler Ultrasound Screening in Paediatric Sickle Cell Disease: A European Multi-Centre Perspective.

Authors:  Baba P D Inusa; Laura Sainati; Corrina MacMahon; Raffaella Colombatti; Maddalena Casale; Silverio Perrotta; Paola Rampazzo; Claire Hemmaway; Soundrie T Padayachee
Journal:  J Clin Med       Date:  2019-12-24       Impact factor: 4.241

Review 5.  Opioids and Sickle Cell Disease: From Opium to the Opioid Epidemic.

Authors:  Samir K Ballas
Journal:  J Clin Med       Date:  2021-01-23       Impact factor: 4.241

Review 6.  Sickle cell disease: a review for the internist.

Authors:  Valeria Maria Pinto; Manuela Balocco; Sabrina Quintino; Gian Luca Forni
Journal:  Intern Emerg Med       Date:  2019-08-05       Impact factor: 5.472

7.  How I Treat Acute and Persistent Sickle Cell Pain.

Authors:  Samir K Ballas
Journal:  Mediterr J Hematol Infect Dis       Date:  2020-09-01       Impact factor: 2.576

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.